Zhengwen Liu Selected Research

Zhengwen Liu Research Topics

Disease

41	Infections 02/2021 - 12/2004
14	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2014
14	Chronic Hepatitis B 11/2020 - 01/2010
9	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2018 - 06/2008
8	Fibrosis (Cirrhosis) 12/2019 - 10/2006
8	Liver Diseases (Liver Disease) 01/2019 - 09/2012
5	Chronic Hepatitis C 12/2019 - 10/2006
4	Neoplasms (Cancer) 12/2018 - 03/2013
3	Disease Progression 01/2021 - 02/2010
3	COVID-19 01/2021 - 01/2021
3	Hepatitis B 01/2020 - 01/2018
3	Carcinogenesis 08/2019 - 01/2016
3	Chronic Hepatitis (Chronic Active Hepatitis) 05/2019 - 02/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 12/2010
3	Virus Diseases (Viral Diseases) 01/2016 - 03/2013
3	Diarrhea 07/2011 - 11/2009
2	Hypoxia (Hypoxemia) 04/2022 - 09/2017
2	Disease Resistance 02/2021 - 01/2021
2	Hepatitis 08/2017 - 02/2014
2	Acute Liver Failure (Fulminant Hepatic Failure) 07/2011 - 02/2010
1	Necrosis 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Sleep Wake Disorders 02/2021
1	Sleep Deprivation 02/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Diabetes Mellitus 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Liver Failure 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Coinfection 12/2019

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2010
8	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2004
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
6	Ribavirin (Virazole)FDA LinkGeneric 12/2019 - 08/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2011
5	Hepatitis B e AntigensIBA 01/2018 - 12/2010
4	MucinsIBA 01/2018 - 03/2013
4	InterferonsIBA 08/2014 - 04/2010
3	Alanine Transaminase (SGPT)IBA 01/2022 - 10/2006
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2014
3	RNA (Ribonucleic Acid)IBA 02/2021 - 10/2006
3	DNA (Deoxyribonucleic Acid)IBA 05/2019 - 08/2011
3	3' Untranslated Regions (3' UTR)IBA 01/2018 - 11/2014
3	Hepatitis B Core AntigensIBA 04/2015 - 01/2010
3	CytokinesIBA 08/2014 - 10/2011
3	Interferon-alpha (Interferon Alfa)IBA 06/2013 - 08/2008
3	CTLA-4 AntigenIBA 04/2012 - 11/2011
2	CarbonIBA 04/2022 - 09/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 02/2021
2	Vitamin A (Retinol)FDA LinkGeneric 02/2021 - 08/2019
2	PTX3 proteinIBA 01/2021 - 11/2020
2	AcidsIBA 01/2021 - 01/2016
2	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2014
2	Autophagy-Related Protein 5IBA 01/2020 - 05/2019
2	SofosbuvirIBA 01/2019 - 08/2014
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 03/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018 - 04/2017
2	EnzymesIBA 07/2017 - 12/2009
2	HexokinaseIBA 04/2017 - 01/2016
2	B-Cell Activating FactorIBA 01/2017 - 10/2014
2	Immune Checkpoint ProteinsIBA 12/2016 - 05/2016
2	AlbuminsIBA 07/2016 - 03/2013
2	Therapeutic UsesIBA 01/2016 - 01/2010
2	Immunoglobulin E (IgE)IBA 06/2014 - 05/2013
2	InterleukinsIBA 06/2014 - 05/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2011 - 02/2010
2	Peptides (Polypeptides)IBA 04/2011 - 01/2010
2	OligodeoxyribonucleotidesIBA 04/2011 - 01/2010
2	EpitopesIBA 04/2011 - 01/2010
2	CPG-oligonucleotideIBA 04/2011 - 01/2010
2	xanthohumolIBA 04/2010 - 11/2009
2	Integrin beta3 (GPIIIa)IBA 12/2009 - 06/2008
1	phytaneIBA 04/2022
1	AlkanesIBA 04/2022
1	pristane (pristan)IBA 04/2022
1	ElementsIBA 04/2022
1	AntipyreticsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Uridine Diphosphate (UDP)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	SulfotransferasesIBA 01/2022
1	Plant Growth Regulators (Plant Hormones)IBA 02/2021
1	Long Noncoding RNAIBA 02/2021
1	Biological ProductsIBA 02/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 02/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LipidsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Intergenic DNA (Junk DNA)IBA 01/2020
1	P-300IBA 12/2019
1	glecaprevir and pibrentasvirIBA 12/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 08/2008
1	Mechanical Ventilators (Ventilator) 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Duration of Therapy 12/2019